AU2682299A - Telomerase assay of body fluids for cancer screening and assessment of disease stage and prognosis - Google Patents
Telomerase assay of body fluids for cancer screening and assessment of disease stage and prognosisInfo
- Publication number
- AU2682299A AU2682299A AU26822/99A AU2682299A AU2682299A AU 2682299 A AU2682299 A AU 2682299A AU 26822/99 A AU26822/99 A AU 26822/99A AU 2682299 A AU2682299 A AU 2682299A AU 2682299 A AU2682299 A AU 2682299A
- Authority
- AU
- Australia
- Prior art keywords
- prognosis
- assessment
- body fluids
- cancer screening
- disease stage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7479398P | 1998-02-16 | 1998-02-16 | |
US60074793 | 1998-02-16 | ||
PCT/US1999/003302 WO1999041406A1 (en) | 1998-02-16 | 1999-02-16 | Telomerase assay of body fluids for cancer screening and assessment of disease stage and prognosis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2682299A true AU2682299A (en) | 1999-08-30 |
Family
ID=22121731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU26822/99A Abandoned AU2682299A (en) | 1998-02-16 | 1999-02-16 | Telomerase assay of body fluids for cancer screening and assessment of disease stage and prognosis |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1071808A1 (en) |
JP (1) | JP2002503480A (en) |
AU (1) | AU2682299A (en) |
CA (1) | CA2321259A1 (en) |
WO (1) | WO1999041406A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1158055A1 (en) * | 2000-05-26 | 2001-11-28 | Xu Qi University of Teaxs Laboratoire de Leucémie Chen | Method for diagnosing cancers |
ITMI20022743A1 (en) | 2002-12-23 | 2004-06-24 | Ist Naz Stud Cura Dei Tumori | METHOD FOR DETERMINING THE RISK OF APPEARANCE, THE PRESENCE OR THE COURSE OF CANCER DISEASES. |
ATE406463T1 (en) | 2005-04-06 | 2008-09-15 | Maurice Stroun | METHOD FOR CANCER DIAGNOSIS USING DETECTION OF DNA AND RNA IN THE CIRCULATION |
CN106940372A (en) * | 2017-03-06 | 2017-07-11 | 南京中医药大学 | Detect methylene blue, upper conversion nano grain modification fibrosis paper sensor of Telomerase and preparation method thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5830644A (en) * | 1992-05-13 | 1998-11-03 | Geron Corporation | Method for screening for agents which increase telomerase activity in a cell |
US5840490A (en) * | 1995-06-07 | 1998-11-24 | Mcmaster University | Telomerase activity associated with hematological and colorectal malignancies |
-
1999
- 1999-02-16 AU AU26822/99A patent/AU2682299A/en not_active Abandoned
- 1999-02-16 WO PCT/US1999/003302 patent/WO1999041406A1/en not_active Application Discontinuation
- 1999-02-16 JP JP2000531587A patent/JP2002503480A/en active Pending
- 1999-02-16 CA CA002321259A patent/CA2321259A1/en not_active Abandoned
- 1999-02-16 EP EP99907069A patent/EP1071808A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO1999041406A1 (en) | 1999-08-19 |
CA2321259A1 (en) | 1999-08-19 |
EP1071808A1 (en) | 2001-01-31 |
JP2002503480A (en) | 2002-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6141699A (en) | Immunoassay that provides for both collection of saliva and assay of saliva | |
AU1724000A (en) | Diagnostic assay for cancer | |
AU2010699A (en) | Compounds for immunotherapy and diagnosis of breast cancer and methods for theiruse | |
AU5212199A (en) | Methods and kits for diagnosing and determination of the predisposition of diseases | |
EP1144632A3 (en) | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use | |
AU1810899A (en) | Neuropilins and use thereof in methods for diagnosis and prognosis of cancer | |
AU1465801A (en) | Methods for cancer prognosis and diagnosis | |
AU2291299A (en) | Promoter regions of the mouse and human telomerase rna component genes | |
AU2002240336A1 (en) | Methods for the diagnosis and treatment of tumors employing the hepsin gene | |
GB2327497B (en) | Diagnostic assay for cancer | |
AU6425800A (en) | Agents for the diagnosis, prognosis and treatment of malignant diseases | |
EP1164838A4 (en) | Screening assay for antagonists of fgfr-mediated malignant cell transformation and tumor formation | |
GB9811598D0 (en) | Diagnosis and treatment of cancer | |
AU2682299A (en) | Telomerase assay of body fluids for cancer screening and assessment of disease stage and prognosis | |
GB0011439D0 (en) | Cancer diagnosis and assays for screening | |
EP1271152A4 (en) | Method of examining cancer by assaying autoantibody against mdm2 and reagent therefor | |
AU3972899A (en) | Analysis of gene family expression | |
AU4150999A (en) | Method and kit for early diagnosis of cancer | |
AU2001243965A1 (en) | Gastric emptying test-kit and method of testing gastric emptying of solid meal | |
AU7713498A (en) | Immunoassay for the detection of cancer | |
EP0951484A4 (en) | Colon cancer kh-1 and n3 antigens | |
AUPQ037799A0 (en) | Methods for diagnosing and/or predicting the risk of gastric cancer | |
AU1198899A (en) | Reagents and immunoassay for the detection and quantitative determination of mycothiol and precursors thereof | |
AU2002322066A1 (en) | N-terminally truncated galectin-3 and antibodies for treating cancer | |
AU2002306600A1 (en) | Sperm protein 17 for the diagnosis and treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |